Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 133 out of 492
4918 citations found

Disproportionate loss of excitatory inputs to smaller phrenic motor neurons following cervical spinal hemisection

Rana, S;Zhan, WZ;Mantilla, CB;Sieck, GC;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses

Bhuiyan, MS;Kalsy, A;Arifuzzaman, M;Charles, RC;Harris, JB;Calderwood, SB;Qadri, F;Ryan, ET;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Antigens for immunization and laboratory assays.

    Purified Vi polysaccharide and DT-conjugated Vi polysaccharide (Vi-DT) (both gifts from the International Vaccine Institute, IVI, in South Korea), and CT (CT; List Biological Laboratories Inc., Campbell, CA) were used for immunizations. Each mouse was transcutaneously immunized with 25 µg of Vi, 25 µg of Vi in Vi-DT conjugate, or 10 µg of CT alone or as an adjuvant with Vi or Vi-DT. Typhim Vi (Sanofi Aventis, Bridgewater, NJ), CT, and keyhole limpet hemocyanin (KLH; Sigma Chemical Co., St. Louis, MO) were used for detection of immunologic responses.

    Immunization regimen and schedule.
    Five different groups of mice (N = 10–15 each) were immunized transcutaneously as previously described13 with CT, Vi, Vi conjugated with DT (Vi-DT), or Vi or Vi-DT with CT as an adjuvant.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Inhibition of CFTR-mediated intestinal chloride secretion by a fungus-derived arthropsolide A: Mechanism of action and anti-diarrheal efficacy

Akrimajirachoote, N;Satitsri, S;Sommart, U;Rukachaisirikul, V;Muanprasat, C;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Vascular endothelial growth factor contributes to lung vascular hyperpermeability in sepsis-associated acute lung injury

Tomita, K;Saito, Y;Suzuki, T;Imbaby, S;Hattori, K;Matsuda, N;Hattori, Y;

Product: LPS from Escherichia coli O55:B5

  • Experimental animal models

    In the second series of experiments, mice, under light anesthesia, were instilled intranasally with 60 μg of lipopolysaccharide (LPS) (Escherichia coli 055:B5; List Biological Laboratories, Campbell, CA, USA) in 60 μl of sterile 0.9% NaCl solution. Control animals received equivalent volume of vehicle saline solution. When bevacizumab, which neutralizes VEGF and blocks its signal transduction through VEGF receptors (Papadopoulos et al. 2012), was used, it was intravenously given to mice at a dose of 40 μg at 60 min before administration of LPS. Animals were euthanized at 24 h after LPS challenge. All experimental data were analyzed in a blinded fashion.

    Product #203A – LPS from Escherichia coli O55:B5

Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine Response

Johnson, B;McAlister, S;McGuire, H;Palanivelu, V;Stevenson, A;Richmond, P;Palmer, D;Metcalfe, J;Prescott, S;Wood, F;Fazekas de St Groth, B;Linden, M;Fear, M;Fear, V;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Diphtheria-Tetanus-Acellular Pertussis Multiplex Immunoassay

    Total IgG concentrations against vaccine antigens pertussis toxin (PT), pertactin (PRN), filamentous hemagglutinin (FHA), fimbriae 2/3 (FIM 2/3), tetanus toxin (TT), and diphtheria toxoid (DT) were measured using an in-house multiplex bead-based immunoassay. PT, PRN, and FHA were kindly provided by GlaxoSmithKline (Belgium). TT was purchased from Sigma-Aldrich while DT and FIM 2/3 was sourced from List biological laboratories (USA). A standard curve was generated using a 10-step 3-fold serial dilution of an in-house reference sera previously quantified against National Institute for Biological Standards and Control reference sera: PT (06/140), TT (TE-3), and DT (10/262). The concentration of FIM 2/3 IgG was previously assigned to 06/140 by an international collaborative study (22). Blanks and two QC samples were included on every plate to calculate% critical variance across all assays, which fell between 6 and 12.7%. Assay specificity was determined using inhibition and interference assays. No cross reactivity was detected (data not shown).

    Product #150 – Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae
    Product #186 – Fimbriae 2/3 from B. pertussis

Flow cytometric identification of Tfh13 cells in mouse and human

Chen, JS;Grassmann, JDS;Gowthaman, U;Olyha, SJ;Simoneau, T;Berin, MC;Eisenbarth, SC;Williams, A;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Reagents

    Allergens

    Cholera toxin (lots 10165A1 and 10167A2; List Biological Laboratories, …

    Immunization and LN collection (see note 1)

    1. Immunize mice with allergen (eg, intranasal A alternata/NP-OVA, intragastric peanut/cholera toxin).9
    a. Intranasal immunization: For each mouse, prepare 10 μg A alternata extract and 25 μg NP-OVA in 50 μL PBS. Anesthetize mice with methoxyflurane using the open-drop method. Once the mice are under anesthesia and their breathing is slow and steady, administer 50 μL of antigen diluted in PBS through the nares using a pipette.
    b. Intragastric immunization: For each mouse, prepare 5 mg ground peanut and 10 μg cholera toxin in 200 μL 0.2 mol/L sodium bicarbonate. Anesthetize mice with 30% isoflurane using the open-drop method. Once the mice are under anesthesia, gently gavage 200 μL of antigen diluted in 0.2 mol/L sodium bicarbonate using a feeding tube connected to a 1-mL syringe.

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes

Patel, VI;Booth, JL;Dozmorov, M;Brown, BR;Metcalf, JP;

Product: Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

  • Protective Antigen Binding Assays

    For all PA binding assays, activated PA (63 kDa, List Biological Laboratories, Inc.; Campbell, CA, USA) was labeled using an Alexa Fluor® 647 Microscale Protein Labeling Kit (Molecular Probes; Waltham, MA, USA) following the manufacturer’s instructions. RAW 264.7, human BAL cells, and human leukocytes were processed as described for anthrax surface receptor expression through the point of Fc receptor blocking. At this point, cells were either left untreated, or incubated with 3000 or 10,000 ng/mL unlabeled PA as indicated for 30 min on ice. Cells were then exposed to AF647-labeled PA at 10, 100, or 1000 ng/mL for an additional 30 min on ice. In the case of lung and blood cells, antibodies used for cell subset-specific identification were also added at the same time as AF647-PA. All samples were centrifuged at 300× g for 5 min and washed twice with 1X PBS-2. Samples were fixed with 2% paraformaldehyde prior to flow cytometry.

    Product #174 – Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation

Horiuchi, H;Parajuli, B;Komiya, H;Ogawa, Y;Shijie, J;Takahashi, K;Azuma, Y;Tanaka, F;Suzumura, A;Takeuchi, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Endoplasmic reticulum stress in the dorsal root ganglia regulates large-conductance potassium channels and contributes to pain in a model of multiple sclerosis

Yousuf, MS;Samtleben, S;Lamothe, SM;Friedman, TN;Catuneanu, A;Thorburn, K;Desai, M;Tenorio, G;Schenk, GJ;Ballanyi, K;Kurata, HT;Simmen, T;Kerr, BJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer